This is part of a larger recall. The most authoritative record is FDA-Device / Z-2232-2026.
Medline anesthesia and spinal anesthesia trays recalled for bupivacaine quality issues
Medline anesthesia trays recalled for bupivacaine quality concerns
Medline distributed anesthesia and spinal anesthesia trays containing bupivacaine hydrochloride in dextrose injection that was recalled by the supplier due to quality issues. The concerns include problems with microbiology testing data and reports that the medication may not work as expected.
- If you have received or are using any of the affected Medline anesthesia trays (SKU DYNJRA1355A or DYNJRA2151), contact Medline to verify if your lot is affected.
- Do not use affected kits for patient procedures until you confirm with Medline or your supplier that your lot is not involved in the recall.
- Healthcare facilities should review their inventory against the lot numbers listed in the recall notice.
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2231-2026More Medline Industries, LP recalls
- FDA-Device2026-06-03Medline EYE TRAY-LF medical kit recalled for mismatched syringes
- FDA-Device2026-05-20Medline Namic Preceptor blood pressure manifold recalled for particulate contamination
- FDA-Device2026-05-20Medline TAVI medical convenience kits recalled for particulate contamination in fluid path
- FDA-Device2026-05-20Medline medical convenience kits with Namic Manifold recalled for particulate contamination
- FDA-Device2026-05-20Medline cardiac catheterization manifold kits recalled for particulate contamination
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief